For drug profile see link ^

Therapeutic uses

Primary and renovascular hypertension
  • Effects on cardiovascular system
    Produces arterial and venous dilatione
    reduces arterial and venous pressures

  • Effects on kidney
    Promotes natriuresis and diuresis
    Decreases Blood volume (lowers BP)

Effective in hyper-reninemic hypertension but still reduces BP in patients with low to normal renin levels (maybe due to bradykinin)

Additionally different ethnicities produce different levels on renin and will respond differently

Inhibition of Ang II production also crucial for proinflammatory and profibrotic effects of HTN

Chronic heart failure

reduced afterload
reduced preload
reduced sympathetic activation

and renal disease diabetes post MI stroke prophylaxis etc (MED3)

Adverse effects

  • bradykinin related ADRs
    • persistent dry cough and rarely angioedema
  • initial hypotension
  • rash
  • disturbed sense of taste
  • foetal abnormalites
  • can lead to renal issues
    contraindicated in angioedema can cause swelling